AU3916397A - Biotherapy of cancer by targeting tp-3/p80 - Google Patents
Biotherapy of cancer by targeting tp-3/p80Info
- Publication number
- AU3916397A AU3916397A AU39163/97A AU3916397A AU3916397A AU 3916397 A AU3916397 A AU 3916397A AU 39163/97 A AU39163/97 A AU 39163/97A AU 3916397 A AU3916397 A AU 3916397A AU 3916397 A AU3916397 A AU 3916397A
- Authority
- AU
- Australia
- Prior art keywords
- biotherapy
- targeting
- cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
- A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
- A61K47/6811—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin
- A61K47/6817—Toxins
- A61K47/6819—Plant toxins
- A61K47/6825—Ribosomal inhibitory proteins, i.e. RIP-I or RIP-II, e.g. Pap, gelonin or dianthin
Landscapes
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Toxicology (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Botany (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US1997/014439 WO1999008710A1 (en) | 1997-08-15 | 1997-08-15 | BIOTHERAPY OF CANCER BY TARGETING TP-3/p80 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU3916397A true AU3916397A (en) | 1999-03-08 |
Family
ID=22261460
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU39163/97A Abandoned AU3916397A (en) | 1997-08-15 | 1997-08-15 | Biotherapy of cancer by targeting tp-3/p80 |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU3916397A (en) |
| WO (1) | WO1999008710A1 (en) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5541297A (en) * | 1988-04-01 | 1996-07-30 | Immunomedics, Inc. | Therapeutic conjugates of toxins and drugs |
| US5690935A (en) * | 1995-01-13 | 1997-11-25 | Regents Of The University Of Minnesota | Biotherapy of cancer by targeting TP-3/P80 |
-
1997
- 1997-08-15 AU AU39163/97A patent/AU3916397A/en not_active Abandoned
- 1997-08-15 WO PCT/US1997/014439 patent/WO1999008710A1/en active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| WO1999008710A1 (en) | 1999-02-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU9209998A (en) | Steerable antenna system | |
| AU4283099A (en) | Antenna assembly | |
| AUPO721997A0 (en) | Anticancer compounds | |
| AU1904500A (en) | Shaped-charge liner | |
| AU6761196A (en) | Integrated directional antenna | |
| AU1773699A (en) | Antenna | |
| AUPP635298A0 (en) | Plasma antenna | |
| AUPQ071299A0 (en) | Vitamin directed dual targeting therapy | |
| AU2084799A (en) | Quadrifilar antenna | |
| AU9808498A (en) | Directional antenna assembly for vehicular use | |
| AU4652496A (en) | Biotherapy of cancer by targeting tp-3/p80 | |
| AU4823599A (en) | Prostate cancer-associated genes | |
| AU5779499A (en) | Organelle targeting sequences | |
| AU5784796A (en) | Antenna assembly | |
| AUPO536797A0 (en) | Protected aminosugars | |
| AUPQ268799A0 (en) | Landmine protection improvements | |
| AU1240099A (en) | Antenna structure | |
| AU5462699A (en) | Prostate derived ets factor | |
| AU6369600A (en) | Ground based antenna assembly | |
| AU6417799A (en) | Matrix-remodeling genes | |
| AU6537798A (en) | Targeted cytolysis of cancer cells | |
| AU3389499A (en) | Explosives booster | |
| AU6300798A (en) | Antitumor genetic constructs | |
| AU3916397A (en) | Biotherapy of cancer by targeting tp-3/p80 | |
| AU5664799A (en) | Ground related arrangement |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |